Lung cancer patients' own immune cells may halt tumor growth in new trial

NCT ID NCT06455917

Recruiting now Disease control Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 24, 2026 · Updated 28 times

Summary

This study tests a treatment using immune cells taken from a patient's own lung tumor. These cells are grown in a lab and then given back to the patient to attack the cancer. The goal is to see if this approach can stop or slow the cancer from growing for at least 6 months. The trial is for 30 adults with advanced non-small cell lung cancer that has worsened after standard treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Medical Oncology, University Hospital Basel
RECRUITING

Basel, Canton of Basel-City, 4031, Switzerland

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

LUNG CANCER (NSCLC) NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER